Transformation-defective adenovirus 5 E1A mutants exhibit antioncogenic properties in human BLM melanoma cells

Cancer Gene Therapy

Volumn 7, Issue 7, 2000, Pages 1043-1050

  Dickopp, Alexandra ^a   Esche, Helmut ^a   Swart, Guido ^b   Seeber, Siegfried ^a   Kirch, Hans Christoph ^a   Opalka, Bertram ^a  

^a UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

BLM cells; E1A; Gene therapy; Melanoma; Tumor suppression

Indexed keywords

VIRUS PROTEIN;

ADENOVIRUS; ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; NUDE MOUSE; PHENOTYPE; PRIORITY JOURNAL; VIRUS MUTANT; VIRUS TRANSFORMATION;

ADENOVIRIDAE; ANIMALIA; HUMAN ADENOVIRUS TYPE 5; MUS MUSCULUS; RODENTIA;

EID: 0033930587     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700206     Document Type: Article

References (50)

1. Nevins JR. Adenovirus E1A-dependent transactivation of transcription. Cancer Biol. 1990;1:59-68.
2. Shenk T, Flint SJ. Transcriptional and transforming activities of the adenovirus E1A proteins. Adv Cancer Res. 1991;57:47-85.
3. Ruley HE. Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature. 1983;304:602-606.
4. Frisch SM. Antioncogenic effect of adenovirus E1A in human tumor cells. Proc Natl Acad Sci USA. 1991;88:9077-9081.
5. Frisch SM, Dolter KE. Adenovirus E1a-mediated tumor suppression by a c-erbB-2/neu-independent mechanism. Cancer Res. 1995;55:5551-5555.
6. Chinnadurai G. Adenovirus E1a as a tumor-suppressor gene. Oncogene. 1992;7:1255-1258.
7. Mymryk JS. Tumour-suppressive properties of the adenovirus 5 E1A oncogene. Oncogene. 1996;13:1581-1589.
8. Yan DH, Chang LS, Hung MC. Repressed expression of the HER-2/c-erbB-2 proto-oncogene by the adenovirus E1a gene products. Oncogene. 1991;6:343-345.
9. Chen H, Hung MC. Involvement of co-activator p300 in the transcriptional regulation of the HER-2/neu gene. J Biol Chem. 1997;272:6101-6104.
10. Chen H, Yu D, Chinnadurai G, Karunagaran D, Hung MC. Mapping of adenovirus 5 E1A domains responsible for suppression of new-mediated transformation via transcriptional repression of neu. Oncogene. 1997;14:1965-1971.
11. Frisch SM. E1a induces the expression of epithelial characteristics. J Cell Biol. 1994;127:1085-1096.
12. Hortobagyi GN, Hung MC, Lopez-Berestein G. A phase I multicenter study of E1A gene therapy for patients with metastatic breast cancer and epithelial ovarian cancer that overexpresses HER-2/neu or epithelial ovarian cancer. Hum Gene Ther. 1998;9:1775-1798.
13. Hung MC, Xia W, Ueno NT, et al. The E1A phase I gene therapy for patients with breast and ovarian cancers: further characterization of molecular markers. Proc 2nd Annu Meet Am Soc Gene Ther. 1999;167A. Abstract.
14. Pozzatti R, Muschel R, Williams J, et al. Primary rat embryo cells transformed by one or two oncogenes show different metastatic potentials. Science. 1986;232:223-227.
15. Frisch SM, Reich R, Collier IE, Genrich LT, Martin G, Goldberg GI. Adenovirus E1A represses protease gene expression and inhibits metastasis of human tumor cells. Oncogene. 1990;5:75-83.
16. Yu D, Hamada J, Zhang H, Nicolson GL, Hung M-C. Mechanisms of c-erbB2/neu oncogene-induced metastasis and repression of metastatic properties by adenovirus 5 E1A gene products. Oncogene. 1992;7:2263-2270.
17. Hennig G, Behrens J, Truss M, Frisch S, Reichmann E, Birchmeier W. Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo. Oncogene. 1995;11: 475-484.
18. Offringa R, Smits AM, Houweling A, Bos JL, van der Eb AJ. Similar effects of adenovirus E1A and glucocorticoid hormones on the expression of the metalloprotease stromelysin. Nucleic Acids Res. 1988;16:10973-10984.
19. Somasundaram K, Jayaraman G, Williams T, Moran E, Frisch SM, Thimmapaya B. Repression of a matrix metalloprotease gene by E1A correlates with its ability to bind to cell type-specific transcription factor AP-2. Proc Natl Acad Sci USA. 1996;93:3088-3093.
20. Santoro M, Battaglia C, Zhang L, et al. Cloning of the rat tissue inhibitor of metalloproteinase type L 2 (TIMP-2) gene: analysis of its expression in normal and transformed thyroid cells. Exp Cell Res. 1994;213:398-403.
21. Günthert U, Hofmann M, Rudy W, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell. 1991;65:13-24.
22. Hofmann M, Rudy W, Günthert U, et al. A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells. Cancer Res. 1993;53:1516-1521.
23. Steeg PS, Bevilacqua G, Pozzatti R, Liotta LA, Sobel ME. Altered expression of NM23, a gene associated with low tumor metastatic potential, during adenovirus 2 E1a inhibition of experimental metastasis. Cancer Res. 1988;48: 6550-6554.
24. Steeg PS, Bevilaqua G, Kopper L, et al. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst. 1988;80:200-204.
25. Lillie JW, Green MR. Transcription activation by the adenovirus E1a protein. Nature. 1989;338:39-44.
26. Abraham SE, Lobo S, Yaciuk P, Wang HG, Moran E. p300, and p300-associated proteins, are components of TATA-binding protein (TBP) complexes. Oncogene. 1993; 8:1639-1647.
27. Lillie JW, Loewenstein PM, Green MR, Green M. Functional domains of adenovirus type 5 E1a proteins. Cell. 1987;50:1091-1100.
28. Moran E, Zerler B, Harrison TM, Mathews MB. Identification of separate domains in the adenovirus E1A gene for immortalization activity and the activation of virus early genes. Mol Cell Biol. 1986;6:3470-3480.
29. Schneider JF, Fisher F, Goding CR, Jones NC. Mutational analysis of the adenovirus E1a gene: the role of transcriptional regulation in transformation. EMBO J. 1987;6:2053-2060.
30. Whyte P, Ruley HE, Harlow E. Two regions of the adenovirus early region 1A proteins are required for transformation. J Virol. 1988;62:257-265.
31. Douglas JL, Gopal L, Krishnan S, Quinlan MP. Modulation of transformation of primary epithelial cells by the second exon of the Ad5 E1A 12S gene. Oncogene. 1991;6:2093-2103.
32. Schaeper U, Boyd JM, Verma S, Uhlmann E, Subramanian T, Chinnadurai G. Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation [published erratum appears in Proc Natl Acad Sci USA. 1998; 95:14584]. Proc Natl Acad Sci USA. 1995;92:10467-10471.
33. Schaeper U, Boyd JM, Verma S, Uhlmann E, Subramanian T, Chinnadurai G. Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation [published erratum appears in Proc Natl Acad Sci USA. 1998; 95:14584]. Proc Natl Acad Sci USA. 1995;92:10467-10471.
34. Subramanian T, La Regina M, Chinnadurai G. Enhanced ras oncogene mediated cell transformation and tumorigenesis by adenovirus 2 mutants lacking the C-terminal region of E1a protein. Oncogene. 1989;4:415-420.
35. Boyd JM, Subramanian T, Schaeper U, La Regina M, Bayley S, Chinnadurai G. A region in the C-terminus of adenovirus 2/5 E1a protein is required for association with a cellular phosphoprotein and important for the negative modulation of T24-ras-mediated transformation, tumorigenesis, and metastasis. EMBO J. 1993;12:469-478.
36. Graham FL, Smiley J, Russell WC, Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol. 1977;36:59-74.
37. Whittaker JL, Byrd PJ, Grand RJ, Gallimore PH. Isolation and characterization of four adenovirus type 12-transformed human embryo kidney cell lines. Mol Cell Biol. 1984;4:110-116.
38. Byrd P, Brown KW, Gallimore PH. Malignant transformation of human embryo retinoblasts by cloned adenovirus 12 DNA. Nature. 1982;298:69-71.
39. Haley KP, Overhauser J, Babiss LE, Ginsberg HS, Jones NC. Transformation properties of type 5 adenovirus mutants that differentially express the E1A gene products. Proc Natl Acad Sci USA. 1984;81:5734-5738.
40. van Groningen JJM, Cornelissen IMAH, van Muijen GNP, Bloemers HPJ, Swart GWM. Simultaneous suppression of progression marker genes in the highly malignant human melanoma cell line BLM after transfection with the adenovirus-5 E1A gene. Biochem Biophys Res Commun. 1996;225:808-816.
41. Van Muijen GN, Cornelissen LM, Jansen CF, et al. Antigen expression of metastasizing and non-metastasizing human melanoma cells xenografted into nude mice. Clin Exp Metastasis. 1991;9:259-272.
42. Kuppuswamy M, Chinnadurai G. Cell type-dependent transformation by adenovirus 5 E1a proteins. Oncogene. 1988;2:567-572.
43. Montell C, Courtois G, Eng C, Berk A. Complete transformation by adenovirus 2 requires both E1A proteins. Cell. 1984;36:951-961.
44. Moran E, Mathews MB. Multiple functional domains in the adenovirus E1A gene. Cell. 1987;48:177-178.
45. Whyte P, Williamson NM, Harlow E. Cellular targets for transformation by the adenovirus E1A proteins. Cell. 1989;56:67-75.
46. Rumpf H, Esche H, Kirch HC. Two domains within the adenovirus type 12 E1A unique spacer have disparate effects on the interaction of E1A with P105-Rb and the transformation of primary mouse cells. Virology. 1999;257: 45-53.
47. Cook JL, Walker TA, Lewis AM Jr, Ruley HE, Graham FL, Pilder SH. Expression of the adenovirus E1A oncogene during cell transformation is sufficient to induce susceptibility to lysis by host inflammatory cells. Proc Natl Acad Sci USA. 1986;83:6965-6969.
48. Sánchez-Prieto R, Quinatanilla M, Martín P, et al. In vivo antitumor effect of retrovirus-mediated gene transfer of the adenovirus E1A gene. Cancer Gene Ther. 1998;5:215-224.
49. Paul RW, Liao Y, Zhang S, et al. In vivo tumor inhibitory activity of the C-terminal fragment of the adenovirus 5 E1A protein. Proc 2nd Annu Meet Am Soc Gene Ther. 1999;176A. Abstract.
50. Sánchez-Prieto R, Lleonart M, Ramón y Cajal S. Lack of correlation between p53 protein level and sensitivity to DNA-damaging agents in keratinocytes carrying adenovirus E1a mutants. Oncogene. 1995;11:675-682.